SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0000950170-23-011363
Filing Date
2023-03-31
Accepted
2023-03-31 16:04:23
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B3 424b3_march_2023_pipe.htm 424B3 411055
2 GRAPHIC img113891770_0.jpg GRAPHIC 13825
3 GRAPHIC img113891770_1.jpg GRAPHIC 60725
4 GRAPHIC img113891770_2.jpg GRAPHIC 13825
  Complete submission text file 0000950170-23-011363.txt   531326
Mailing Address 30 BROADWICK STREET LONDON X0 W1F 8LX
Business Address 30 BROADWICK STREET LONDON X0 W1F 8LX 44 020 7788 7414
Virax Biolabs Group Ltd (Filer) CIK: 0001885827 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-270734 | Film No.: 23787481
SIC: 2835 In Vitro & In Vivo Diagnostic Substances